Core Points - The company has not distributed cash dividends or bonus shares during the reporting period [3] - The company has implemented a rectification plan to address issues related to shareholding by proxy, ensuring accurate disclosure of shareholder information [5] - The board of directors and supervisory board have both approved the 2025 semi-annual report, confirming its compliance with legal and regulatory requirements [10][12] Company Overview - The company is identified as Jilin Province Jichang Yisheng Pharmaceutical Co., Ltd. with the stock code 002566 [1] - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [6][7] Financial Information - The company has not reported any preferred shareholders or related data during the reporting period [8] - The company has not issued any bonds that are still in existence as of the date of the semi-annual report [9]